Article Archive
CuraGen's 1st-qtr net loss narrows to $6.8M
26 May 2008
PDL's 1st-qtr 2008 net loss triples to $62M
26 May 2008
ArQule's 1st-qtr loss narrows to $13.9M
26 May 2008
High EE healing rate for TAK-360MR
26 May 2008
First CV polypill to enter US clinical testing
26 May 2008
Strong early data on Destiny's MRSA drug
26 May 2008
Strong IBS-C data for Sucampo/Takeda's Amitiza
26 May 2008
46% of patients on NPS SBS drug see PN drop
26 May 2008
GM monkeys may hold the cure to Huntington's
26 May 2008
"Approvable" letter for Salix' balsalazide
26 May 2008
Inspire gets milestone from Santen
26 May 2008
Bayer debuts reformulated Leukine in USA
26 May 2008
FDA reissues warning on mycopheno drugs
26 May 2008
FDA accepts Reloxin BLA, Ipsen gets $25M
26 May 2008
Strong data for Bayer's Avelox in CAP
26 May 2008
CR UK to develop AstraZeneca drug
26 May 2008
US seniors cut back on drugs, AARP warns
26 May 2008
Lung cancer lowest in US federal funding
26 May 2008
New alliance to improve medicines access in DCs
26 May 2008
Nexavar improves overall survival 47.3%
26 May 2008
PIP recommendations from EMEA's PDCO
26 May 2008
New US marketing rules for Rx drug plans
26 May 2008
US measles surge blamed on vaccine fears
26 May 2008
US FDA approves BASF excipient Kollicoat
26 May 2008
Transdel closes $4M financing
26 May 2008
Bayer Schering debuts MS awareness initiative
26 May 2008
Pharma M&A rumor mill in top gear
26 May 2008
NicOx swings to a loss in 1st-qtr p R&D costs
26 May 2008
Speedel's 1st-qtr 2008 revenues disappoint
26 May 2008
GPC's loss improves 60% on lower costs
26 May 2008
Tekturna combo "twice as effective" as solo HCT
26 May 2008
Debiopharm signs Salvacyl market deal
26 May 2008
Strong Ph II data for Novartis' MenB vacc
26 May 2008
Almirall's 1st-qtr net income falls 9.9%
26 May 2008
Solvay's 1st-qtr 2008 net income rises 1%
26 May 2008
Crucell's 1st-qtr 2008 loss halves on sales
26 May 2008
Tough US Pharma bar will stay; GSK chief
26 May 2008
Generex produces clinical samples of MetControl
19 May 2008
Tokyo stocks to May 12, 2008
19 May 2008
FDA clears Lilly's Strattera in ADHD maintenance
19 May 2008
Cytopia licenses kinase inhibitors to CT
19 May 2008
Strong long-term psoriasis Raptiva data
19 May 2008
American Oriental up on OTC revenue
19 May 2008
US CDC recommends shingles vaccine for over 60s
19 May 2008
Wyeth debuts Pristiq in US pharmacies
19 May 2008
Abbott reports two-year data for Xience V
19 May 2008
GSK launches once-daily ReQuip XL in UK
19 May 2008
France's Social Security savings on drugs
19 May 2008
Bayer pulls remaining stocks of Trasylol
19 May 2008
US drug spending curbed by generics
19 May 2008
France's Cancer Institute faces closure
19 May 2008
Cancer Research Tech opens lab in Cambridge, UK
19 May 2008
PharmaMar's Yondelis cleared in South Korea
19 May 2008
Hospira launches Retacrit in UK
19 May 2008
Biovitrum AB to focus on specialty care products
19 May 2008
New appointments at China Sky One
19 May 2008
US Federal Court denies Sanofi-Aventis
19 May 2008
Stock Commentary - New York week to May 12, 2008
19 May 2008
NPS appoints Bo Joelsson head of research
19 May 2008
Stock Commentary - Europe - week to May 12, 2008
19 May 2008
Cherries may offer natural arthritis relief
19 May 2008
Spherix reports Naturlose Ph III results
19 May 2008
FDA warns Adolor of further delays for Entereg
19 May 2008
Lundbeck launches melatonin sleep aid
19 May 2008
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
